Resolving sex and gender bias in COVID-19 vaccines R&D and beyond
Vijayasingham, Lavanya, Heidari, Shirin, Munro, Jean, Omer, Saad and MacDonald, Noni, (2022). Resolving sex and gender bias in COVID-19 vaccines R&D and beyond. Human Vaccines & Immunotherapeutics, 1-3
Document type:
Article
Collection:
-
Related Links Link Description 
https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2035142 Link
http://dx.doi.org/10.1080/21645515.2022.2035142 Full text from publisher -
Sub-type Journal article Author Vijayasingham, Lavanya
Heidari, Shirin
Munro, Jean
Omer, Saad
MacDonald, NoniTitle Resolving sex and gender bias in COVID-19 vaccines R&D and beyond Appearing in Human Vaccines & Immunotherapeutics Publication Date 2022-02-10 Place of Publication London Publisher Taylor & Francis Online Start page 1 End page 3 Language eng Abstract The influence of sex and gender in immune response and vaccine outcomes is established in many disease areas, including in COVID-19. Yet, there are notable gaps in the consideration of sex and gender in the analysis and reporting of COVID-19 vaccines clinical trial data. The push for stronger sex and gender integration in vaccines science should be championed by all researchers and stakeholders across the R&D and access ecosystem – not just gender experts. This requires joint action on the tactical framing of customized value propositions (based on stakeholder motivations), the stronger enforcement of existing regulation, tools, and commitments, and aligning the overall agenda to parallel calls on intersectionality, equity diversity and inclusion. UNBIS Thesaurus GENDER
VACCINES
COORDINATION WITHIN UN SYSTEM
SEXKeyword Resolving bias
R&D
COVID-19Copyright Holder The Authors Copyright Year 2022 Copyright type Creative commons DOI 10.1080/21645515.2022.2035142 -
Citation counts 
Search Google Scholar
Access Statistics: 347 Abstract Views - Detailed Statistics Created: Tue, 15 Feb 2022, 17:48:30 JST by Radhika Das on behalf of UNU IIGH